A cohort event monitoring study to characterise use of eplontersen in patients with prior liver transplant and pre-existing severe hepatic impairment and to assess long-term safety among all new users of eplontersen (sTTRing)
A cohort event monitoring study to characterise use of eplontersen in patients with prior liver transplant and pre-existing severe hepatic impairment and to assess long-term safety among all new users of eplontersen (sTTRing)